... Eastern Cooperative Oncology Group: Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, ... [63].Interestingly, the response rate induced by the adminis-tration of peptide alone was minimal, strongly emphasiz-ing the need to test combinations. Results from anongoing phase 3 study in ... continualbasis over time, much as in chronic infections such as formalaria, tuberculosis or HIV. Introducing multiple drugsindividually that increase survival by months may notresult in prolonged...